Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration
Supplemental Material
rcp21009-sup-0001-suppl-data.docx (43 KB)
rcp21009-sup-0002-fig_s1.pdf (6 KB)
rcp21009-sup-0003-fig_s2a.pdf (18 KB)
rcp21009-sup-0004-fig_s2b.pdf (17 KB)
rcp21009-sup-0005-fig_s2c.pdf (20 KB)
rcp21009-sup-0006-fig_s2d.pdf (20 KB)